Logo image
Back
An exploration of healthcare providers values and beliefs that impact treatment recommendations for older adults with myelodysplastic syndromes (MDS)
Dissertation   Open access

An exploration of healthcare providers values and beliefs that impact treatment recommendations for older adults with myelodysplastic syndromes (MDS)

Gayle Jean Logan
Doctor of Nursing Practice (D.N.P.), Drexel University
Nov 2015
DOI:
https://doi.org/10.17918/etd-6490
pdf
Logan_Gayle_20153.14 MBDownloadView
PDF Open Access Open Access (License Unspecified)

Abstract

Myelodysplastic syndromes Nursing
By 2030, the number of older Americans, age 65 - 84 is estimated to reach 72 million representing 20% of the population in the U.S. Myelodysplastic Syndromes (MDS) is a curable form of cancer that occurs primarily in adults over age 65. A variety of treatments are available for this type of hematologic cancer including symptom management, disease modulating drugs and hematopoietic stem cell transplant (HSCT). HSCT has similar success and longevity rates across the lifespan (Sekeres et al., 2011). Yet, patients report a significant decrease in the recommendation of HSCT for patients over age 65 as well as a lack of education about the disease and treatment options from providers. Healthcare providers' values and beliefs directly impact the care provided. The primary aim of this explanatory sequential mixed methods study was to examine underlying values and beliefs among a small purposive convenience sample of healthcare providers who work with older adults (ages 65 and older) diagnosed with MDS. The findings from interviews with 5 advanced practice nurses suggest the availability of treatment options for MDS in older adults is largely dependent upon the values and beliefs of the members of the healthcare team.

Metrics

31 File views/ downloads
62 Record Views

Details

Logo image